Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins

Acta Paediatr Scand Suppl. 1988:347:114-26.

Abstract

With the presently available RIAs, serum levels of IGF-I, IGF-II and somatomedin binding protein can be determined specifically. Basal IGF-I and binding protein levels are low in GH deficiency, and normality of these parameters virtually excludes the condition. If, in a given clinical situation, auxological criteria and IGF-I (binding protein) levels suggest GH deficiency but the diagnosis is rejected by conventional stimulation tests, a further diagnostic work-up is needed, including measurements of spontaneously secreted GH. IGF measurements may serve as tools to disclose the unknown pathogenesis in growth disorders. Short-term responses of IGFs to exogenous GH may assist in defining the GH doses required to induce long-term growth.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Carrier Proteins / blood*
  • Child
  • Child, Preschool
  • Female
  • Growth Disorders / diagnosis
  • Growth Hormone / deficiency*
  • Growth Hormone / therapeutic use
  • Humans
  • Infant
  • Insulin-Like Growth Factor Binding Proteins
  • Insulin-Like Growth Factor I / blood*
  • Insulin-Like Growth Factor II / blood*
  • Male
  • Somatomedins / blood*

Substances

  • Carrier Proteins
  • Insulin-Like Growth Factor Binding Proteins
  • Somatomedins
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
  • Growth Hormone